Gynipral, solution for injections 10mcg/2ml, 2ml x 5 ampoules — Made in Austria — Free Delivery

Product description

• short-term treatment of uncomplicated course of preterm labor: inhibition of uterine contractile activity in patients with a gestational age of 22 to 37 weeks in the absence of medical or gynecological contraindications to tocolytic therapy;
• before turning the fetus from the transverse position;
• as an emergency measure for preterm labor before transporting the pregnant woman to the hospital.

Compound

Contraindications

• hypersensitivity to hexaprenaline or to any component of the preparation;
• the presence of any disease before the 22nd week of pregnancy;
• the use of the preparation as a tocolytic agent in patients with a history of coronary heart disease or in patients with significant risk factors for coronary heart disease;
• the threat of miscarriage during the I and II trimesters of pregnancy;
• any disease of the mother or fetus in which the continuation of pregnancy is dangerous, for example, a severe degree of toxemia, intrauterine infection, vaginal bleeding due to placenta previa, eclampsia or severe preeclampsia, placental abruption or umbilical cord compression;
• intrauterine fetal death, history of lethal congenital anomalies or lethal chromosomal abnormalities;
• bronchial asthma with hypersensitivity to sulfates;
• diseases of the cardiovascular system, in particular tachyarrhythmia, myocarditis, mitral valve disease;
• hyperthyroidism;
• severe liver and kidney disease;
• glaucoma;
• the use of the preparation "Gynipral" is contraindicated in patients with diseases against which the use of beta-agonists may have an undesirable effect, for example, pulmonary hypertension, diseases of the cardiovascular system (hypertrophic obstructive cardiomyopathy or obstruction of blood flow from the left ventricle, for example, aortic stenosis) .

Mode of application

Dosages